This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Precision Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Paige Scarlett Nemec
Introduction
Paige Scarlett Nemec is an innovative inventor based in Durham, NC (US). She is focused on advancing the field of gene editing, particularly in relation to alpha-1 antitrypsin (AAT) deficiency. Although she currently holds no granted patents, her work is paving the way for future developments in genetic therapies.
Latest Patent Applications
Paige's latest patent applications include "Gene Editing Methods for Treating Alpha-1 Antitrypsin (AAT) Deficiency." This application discloses engineered meganucleases that bind and cleave a recognition sequence within the SERPINA1 gene, which encodes alpha-1 antitrypsin (AAT). Additionally, it includes donor polynucleotides that encode functional AAT proteins. The present disclosure also encompasses methods of using such engineered meganucleases and donor polynucleotides to create genetically-modified cells, as well as the use of these compositions for the treatment of AAT deficiency.
Conclusion
Paige Scarlett Nemec is making significant strides in the field of gene editing, with her latest applications focusing on innovative methods to treat AAT deficiency. Her contributions are expected to have a lasting impact on genetic therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile